Logo

tumor sequencing

Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test

The collaboration between Sophia and Memorial Sloan Kettering Cancer Center aims to offer new testing and analytics capabilities to clinicians and researchers.

Genome Insight, Seoul National University Hospital Collaborate on WGS Study of Pediatric Cancer Dx

Caris Life Sciences Adds Everything Genetic as UK Distributor

Everything Genetic will distribute Caris Life Sciences' Molecular Intelligence Tumor Seek NGS-based tumor profiling service in the UK.

Tempus, Children's Oncology Group Expand Genomic Testing Access for Pediatric Cancer Patients

Tempus' xT platform will be used to identify patients likely to match for a trial assessing the efficacy of genetically informed treatments in certain pediatric cancers.

NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling

The guidelines recognize the importance of molecular profiling in diagnosing, treating, and identifying clinical trial opportunities for children with high-grade gliomas. 

Jun 9, 2022

Tempus, Lilly Ink Partnership to Offer No-Cost NGS for Advanced NSCLC Patients

Jun 1, 2022

Avera Health, Sema4 Launch Five-Year Precision Oncology Study

May 18, 2022

Illumina, Allegheny Health Network Collaborate on Study of Cancer Genomic Profiling

May 9, 2022

Tracing Tumor Evolution Through Single-Cell Changes Could Provide Therapeutic Windows 
Premium

May 4, 2022

NGeneBio Receives CE-IVD Mark for NGS-Based Cancer Panel

Apr 19, 2022

Breast Cancer Clues Revealed by Recurrent Tumor Microenvironment Structures

Oct 28, 2021

Kidney Cancer Study Links Checkpoint Immunotherapy Responses to T Cell Features

Oct 7, 2021

Lung Cancer Treatment Response Linked to Cancer-Associated Fibroblast Cell Subtypes

Aug 9, 2021

Single Metastatic Cancer Genome Analysis Appears Sufficient to ID Biomarkers, Treatment Options

Jul 29, 2021

Genomes of Advanced Neuroendocrine Neoplasms Unveil Subtypes, Treatment Clues

Jul 22, 2021

Sema4 Closes SPAC Deal With CM Life Sciences, Raising Approximately $500M
Premium

Jun 4, 2021

Breast Cancer Genomics Study Reveals Recurrent Contributors to Treatment Resistance in Early Disease

Apr 6, 2021

Uterine Leiomyosarcoma Sequences Point to Potentially Targetable Somatic Mutations

Mar 17, 2021

Cancer Heritability Gene Set Expanded With Common Variant Analysis

Feb 26, 2021

Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year
Premium

Feb 5, 2021

Guardant Health Turns to Tumor Tissue Sequencing to Broaden Offering
Premium

Dec 9, 2020

Appendiceal Cancer Sequences Suggest Distinct Mutation Patterns in Early-, Late-Onset Cases

Nov 18, 2020

MSK Study Suggests Germline Tests May Miss Mosaic Cancer Risk Mutations in Some Patients
Premium

Nov 10, 2020

BostonGene, Thomas Jefferson University Partner on Head, Neck Cancer Research

Oct 8, 2020

Germline Genetic Testing After Tumor Sequencing Can Uncover Clinically Actionable Variants

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.